跳至主要内容
临床试验/NCT01261650
NCT01261650终止4 期

Influence of Transcranial Direct Current Stimulation of the Primary Motor Cortex on Pain Sensation in Patients Suffering From Fibromyalgia Syndrome

Karl Landsteiner Institute of Remobilization and Functional Health2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2010年12月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
终止
发起方
入组人数
50
试验地点
2
主要终点
Visual Analoge Scale

研究概览

简要总结

Fibromyalgia is a common chronic pain syndrome characterized by bad treatable chronic widespread pain present at a similar level for at least 3 months. The aim of this study is to examine if 3 weeks of transcranial direct current stimulation is a suitable therapy to reduce chronic pain.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients who have an established diagnosis of fibromyalgia according to the 1990 criteria of the "American College of Rheumatology"
  • Symptoms have been present at a similar level for at least 3 months
  • Stable medication for at least 2 months
  • visual analog scale ≥ 3 (0=no pain; 10=worst possible pain)
  • The patient does not have a disorder that would otherwise explain the pain

排除标准

  • Alcohol/substance abuse
  • Pregnancy
  • Neuropsychiatric disorders
  • Metal implants near stimulation area
  • Cardiac pace maker
  • Local injuries
  • Inflammatory rheumatic disease
  • Acute tumor
  • Acute fracture
  • Well-defined neuropathic induced pain

研究组 & 干预措施

transcranial direct current stimulation

Active Comparator

transcranial direct current stimulation of the primary motor cortex

干预措施: transcranial direct current stimulation (Device)

sham treatment

Sham Comparator

干预措施: sham treatment (Device)

结局指标

主要结局

Visual Analoge Scale

时间窗: Difference Baseline - after treatment

次要结局

  • Quality of Life - SF-36(baseline / after treatment / 1 , 2, 3 months after treatment)
  • IL-6 ELISA(baseline / after treatment / 1,2,3, months after treatment)
  • Fibromyalgia Impact Questionaire(baseline / after treatment / 1,2,3, months after treatment)
  • IL-10 ELISA(baseline / after treatment / 1,2,3, months after treatment)
  • Visual analog scale(1,2,3 months after treatment)
  • TNF-alpha ELISA(baseline / after treatment / 1,2,3, months after treatment)
  • IL-4 ELISA(baseline / after treatment / 1,2,3, months after treatment)

研究者

发起方
Karl Landsteiner Institute of Remobilization and Functional Health
申办方类型
Other

研究点 (2)

Loading locations...

相似试验